Degand T, Monnet E, Durand F, Grandclement E, Ichai P, Borot S, Qualls CR, Agin A, Louvet A, Dumortier J, Francoz C, Dumoulin G, Di Martino V, Dorin R, Thevenot T

Dig Liver Dis. 2015 May 22. pii: S1590-8658(15)00345-X

Clinical laboratory medicine: continuous amelioration with a book of objectives and satisfaction survey.

Reix N, Agin A, Bahram S, Dali-Youcef N, Grucker D, Jaulhac B, Lepiller Q, Lessinger JM, Mauvieux L, Monier L, Schramm F, Stoll-Keller F, Vallat L, Ludes B, Candolfi E, Filisetti D

Ann Biol Clin (Paris). 2015 Apr 14.

Effect of the estrogen receptor antagonist fulvestrant on the cirrhotic rat lung.

Oswald-Mammosser M, Rashid S, Boehm N, Agin A, Geny B, Kerth VS, Charloux A

Fundam Clin Pharmacol. 2015 Mar 7

Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification.

Heurtault B, Reix N, Meyer N, Gasser F, Wendling MJ, Ratomponirina C, Jeandidier N, Sapin R, Agin A

Clin Chem Lab Med. 2014 Mar;52(3):355-62

Thyroid-stimulating hormone and free thyroxine on the ADVIA Centaur immunoassay system: a multicenter assessment of analytical performance.

Reix N, Massart C, d'Herbomez M, Gasser F, Heurtault B, Agin A

Clin Biochem. 2013 Sep;46(13-14):1305-8

Should functional sensitivity of a new thyroid stimulating hormone immunoassay be monitored routinely? The ADVIA Centaur TSH3-UL assay experience.

Reix N, Massart C, Gasser F, Heurtault B, Agin A

Clin Biochem. 2012 Oct;45(15):1260-2

Analogues and insulin assays: In the main and glargine special case.

Agin A, Sapin R

Med Nucl-imag Fonct Metab. 2010 Oct;34(10):571-82.

[New assays of TSH-receptor antibodies: analytical and clinical performances in the diagnosis of Graves' disease]

Massart C, Sapin R, Gibassier J, Agin A, d'Herbomez M

Ann Biol Clin (Paris). 2009 Nov-Dec;67(6):661-7.

Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves disease and for the follow-up of Graves ophthalmopathy.

Massart C, Sapin R, Gibassier J, Agin A, d'Herbomez M

Clin Chem. 2009 Jan;55(1):183-6

Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging.

Harsan LA, Steibel J, Zaremba A, Agin A, Sapin R, Poulet P, Guignard B, Parizel N, Grucker D, Boehm N, Miller RH, Ghandour MS

J Neurosci. 2008 Dec 24;28(52):14189-201.

Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: Bi-insulin IRMA preliminary assessment.

Agin A, Jeandidier N, Gasser F, Grucker D, Sapin R

Clin Chem Lab Med. 2006;44(11):1379-82.

Misleading high thyrotropin results obtained with a two-site immunometric assay involving a chimeric antibody.

Sapin R, Agin A, Gasser F

Clin Chem. 2004 May;50(5):946-8.

Fiche personne Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques

Dr AGIN Arnaud

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Recherche

Publications

Acute-onset delirium in intensive care COVID patients: association of imperfect brain repair with foodborne micro-pollutants.

Environmental exposure to phthalates and dementia with Lewy bodies: contribution of metabolomics.

Assessment of adrenal function in patients with acute hepatitis using serum free and total cortisol.

Clinical laboratory medicine: continuous amelioration with a book of objectives and satisfaction survey.

Effect of the estrogen receptor antagonist fulvestrant on the cirrhotic rat lung.

Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification.

Thyroid-stimulating hormone and free thyroxine on the ADVIA Centaur immunoassay system: a multicenter assessment of analytical performance.

Fast test: clinical practice and interpretation.

Plasma copeptin, a possible prognostic marker in cirrhosis.

Glycemic management of diabetes by insulin therapy.

Should functional sensitivity of a new thyroid stimulating hormone immunoassay be monitored routinely? The ADVIA Centaur TSH3-UL assay experience.

Analogues and insulin assays: In the main and glargine special case.

[New assays of TSH-receptor antibodies: analytical and clinical performances in the diagnosis of Graves' disease]

Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves disease and for the follow-up of Graves ophthalmopathy.

Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging.

Elecsys (R) prolactin immunoassays: from Prolactin to Prolactin II

A direct urinary free cortisol RIA compared with GC-MS on quality control material

Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay.

Insulin analogues: An update

Efficacy of a new blocker against anti-ruthenium antibody interference in the Elecsys free triiodothyronine assay.

Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: Bi-insulin IRMA preliminary assessment.

Misleading high thyrotropin results obtained with a two-site immunometric assay involving a chimeric antibody.

Retrouvez aussi